Overview
James Vredenburgh is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Vredenburgh is rated as an Experienced provider by MediFind in the treatment of Purpura. His top areas of expertise are Glioma, Glioblastoma, Astrocytoma, Brain Tumor, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 74 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Purpura.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
University Of North Carolina At Chapel Hill
Stephan Moll is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Moll is rated as a Distinguished provider by MediFind in the treatment of Purpura. His top areas of expertise are Venous Thromboembolism (VTE), Shwartzman Phenomenon, Deep Vein Thrombosis, Splenectomy, and Bone Marrow Aspiration. Dr. Moll is currently accepting new patients.
Duke Cancer Center Cary
I am a medical oncologist specializing in genitourinary cancers, including prostate, bladder, kidney, and testicular cancer. I primarily see patients at Duke Cancer Centers in Cary and Raleigh, where I focus on providing comprehensive, patient-centered care. Growing up in eastern North Carolina and having lived most of my adult life in the Triangle area, I am deeply connected to the North Carolina community. My approach centers on treating each patient with a focus on their needs and a positive outlook, emphasizing both effective treatment and maintaining a high quality of life. I prioritize having access to the most updated treatment options, enrolling patients in clinical trials, and ensuring they have a strong understanding of their diagnosis and management options. Outside of work, I enjoy traveling and attending sporting events with my wife and our two little boys. Dr. Cockrell is rated as an Experienced provider by MediFind in the treatment of Purpura. His top areas of expertise are Purpura, Bladder Cancer, Thrombocytopenia, Splenectomy, and Orchiectomy.
University Of North Carolina At Chapel Hill
Nigel Key is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Key is rated as an Elite provider by MediFind in the treatment of Purpura. His top areas of expertise are Hemophilia B, Hemophilia A, Blood Clots, Sickle Cell Disease, and Hip Replacement. Dr. Key is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstrocytomaDr. Vredenburgh isElite. Learn about Astrocytoma.
- GlioblastomaDr. Vredenburgh isElite. Learn about Glioblastoma.
- GliomaDr. Vredenburgh isElite. Learn about Glioma.
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Vredenburgh isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Brain TumorDr. Vredenburgh isDistinguished. Learn about Brain Tumor.
- Breast Cancer in MenDr. Vredenburgh isDistinguished. Learn about Breast Cancer in Men.
- EGFR Positive Lung CancerDr. Vredenburgh isDistinguished. Learn about EGFR Positive Lung Cancer.
- Gliomatosis CerebriDr. Vredenburgh isDistinguished. Learn about Gliomatosis Cerebri.
- Large-Cell Lung CarcinomaDr. Vredenburgh isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Advanced
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Vredenburgh isAdvanced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Breast CancerDr. Vredenburgh isAdvanced. Learn about Breast Cancer.
- Embryonal Tumor with Multilayered RosettesDr. Vredenburgh isAdvanced. Learn about Embryonal Tumor with Multilayered Rosettes.
- EpendymomaDr. Vredenburgh isAdvanced. Learn about Ependymoma.
- GliosarcomaDr. Vredenburgh isAdvanced. Learn about Gliosarcoma.
- Inflammatory Breast CancerDr. Vredenburgh isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Vredenburgh isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Immune ThrombocytopeniaDr. Vredenburgh isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Vredenburgh isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Vredenburgh isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Vredenburgh isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Vredenburgh isExperienced. Learn about Angiosarcoma.
